BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Dec 22, 2023
Distillery Therapeutics

Reprogramming IL-1β-expressing macrophages for pancreatic cancer

BioCentury | Oct 13, 2018
Product Development

Bourla’s breadcrumbs to value

How Bourla could reshape drug pricing at Pfizer
BioCentury | Oct 1, 2018
Company News

Pfizer COO Bourla to succeed Read as CEO

BioCentury | Jun 29, 2018
Clinical News

FDA approves CV label update for Pfizer's Celebrex

BioCentury | May 9, 2018
Distillery Therapeutics

Musculoskeletal

BioCentury | Apr 27, 2018
Clinical News

FDA panel affirms safety of Pfizer's Celebrex

BioCentury | Apr 25, 2018
Company News

FDA panel affirms safety of Pfizer's Celebrex

BioCentury | Apr 3, 2018
Distillery Therapeutics

Neurology

BioCentury | Nov 9, 2015
Strategy

Pfizer's growth spurt

How Allergan would fit with Pfizer
BioCentury | Nov 5, 2015
Distillery Therapeutics

Therapeutics: Cyclooxygenase-1 (COX-1); COX-2

Items per page:
1 - 10 of 240